|
OMIM |
Link |
Information gain |
01 |
|
iminoglycinuria
|
[NCBI]
|
0.0150188
|
|
|
d-glyceric acidemia
|
[NCBI]
|
0.00649483
|
|
|
GCE
|
[NCBI]
|
0.00270456
|
|
|
microcephaly, hiatus hernia, and nephrotic syndrome
|
[NCBI]
|
0.00195547
|
|
|
RCD1
|
[NCBI]
|
0.00123883
|
|
|
hyperbilirubinemia, shunt
|
[NCBI]
|
0.00123883
|
|
|
methionine malabsorption syndrome
|
[NCBI]
|
0.00111265
|
|
|
CDAN3
|
[NCBI]
|
0.00101935
|
|
|
AUTS6
|
[NCBI]
|
0.000832282
|
|
|
nephrolithiasis, calcium oxalate
|
[NCBI]
|
0.000711391
|
|
|
IVA
|
[NCBI]
|
0.000629877
|
|
|
GAMT
|
[NCBI]
|
0.000546728
|
|
|
SLE
|
[NCBI]
|
0.000533076
|
|
|
glycinuria with or without oxalate urolithiasis
|
[NCBI]
|
0.000518214
|
|
|
RA
|
[NCBI]
|
0.000466518
|
|
|
propionic acidemia
|
[NCBI]
|
0.000465453
|
|
|
COL1A1
|
[NCBI]
|
0.000400773
|
|
|
sarcosinemia
|
[NCBI]
|
0.000377707
|
|
|
biotinidase deficiency
|
[NCBI]
|
0.000375106
|
|
|
OFC1
|
[NCBI]
|
0.000350573
|
|
|
alpha-methylacetoacetic aciduria
|
[NCBI]
|
0.000314103
|
|
|
phosphoglycerate dehydrogenase deficiency
|
[NCBI]
|
0.000311973
|
|
|
PARK8
|
[NCBI]
|
0.00030785
|
|
|
GLDC
|
[NCBI]
|
0.000286379
|
|
|
GCSH
|
[NCBI]
|
0.000254959
|
|
|
SPS
|
[NCBI]
|
0.00025053
|
|
|
HBB
|
[NCBI]
|
0.00024618
|
|
|
osteogenesis imperfecta, type iia
|
[NCBI]
|
0.000245617
|
|
|
hyperprolinemia, type ii
|
[NCBI]
|
0.000242239
|
|
|
COL7A1
|
[NCBI]
|
0.000235596
|
|
|
MSD
|
[NCBI]
|
0.000227015
|
|
|
AMT
|
[NCBI]
|
0.000220485
|
|
|
LRRK2
|
[NCBI]
|
0.000205097
|
|
|
3-@methylcrotonyl-coa carboxylase 1 deficiency
|
[NCBI]
|
0.000204845
|
|
|
EBDSC
|
[NCBI]
|
0.000195869
|
|
|
COL1A2
|
[NCBI]
|
0.00019445
|
|
|
phosphoribosylpyrophosphate synthetase superactivity
|
[NCBI]
|
0.000190281
|
|
|
ACH
|
[NCBI]
|
0.000187627
|
|
|
hydroxyprolinemia
|
[NCBI]
|
0.000182445
|
|
|
osteogenesis imperfecta, type i
|
[NCBI]
|
0.00017646
|
|
|
acyl-coa dehydrogenase, medium-chain, deficiency of
|
[NCBI]
|
0.000163858
|
|
|
COL3A1
|
[NCBI]
|
0.00016018
|
|
|
SCA14
|
[NCBI]
|
0.000156844
|
|
|
formiminotransferase deficiency
|
[NCBI]
|
0.000140741
|
|
|
SLC6A9
|
[NCBI]
|
0.000136894
|
|
|
hyperprolinemia, type i
|
[NCBI]
|
0.000136462
|
|
|
DLB
|
[NCBI]
|
0.000132563
|
|
|
indolylacroyl glycinuria with mental retardation
|
[NCBI]
|
0.000129395
|
|
|
phosphoserine aminotransferase deficiency
|
[NCBI]
|
0.000129395
|
|
|
cysteine peptiduria
|
[NCBI]
|
0.000129395
|
|
|
tachycardia, hypertension, microphthalmia, and hyperglycinuria
|
[NCBI]
|
0.000129395
|
|
|
hyperuricemia, infantile, with abnormal behavior and normal hypoxanthine guanine phosphoribosyltransferase
|
[NCBI]
|
0.000129395
|
|
|
acyl-coa dehydrogenase, short-chain, deficiency of
|
[NCBI]
|
0.00011452
|
|
|
ACADM
|
[NCBI]
|
0.000113447
|
|
|
HBG2
|
[NCBI]
|
0.000104945
|
|
|
HBA1
|
[NCBI]
|
0.000104858
|
|
|
ehlers-danlos syndrome, type iv, autosomal dominant
|
[NCBI]
|
0.000103727
|
|
|
WZS
|
[NCBI]
|
9.78821e-05
|
|
|
WARBM
|
[NCBI]
|
9.78821e-05
|
|
|
TS
|
[NCBI]
|
9.78821e-05
|
|
|
COD3
|
[NCBI]
|
9.78821e-05
|
|
|
epidermolysis bullosa, pretibial
|
[NCBI]
|
9.78821e-05
|
|
|
VWS
|
[NCBI]
|
9.51443e-05
|
|
|
HBFQTL1
|
[NCBI]
|
9.51443e-05
|
|
|
COL2A1
|
[NCBI]
|
9.29183e-05
|
|
|
MM
|
[NCBI]
|
8.93664e-05
|
|
|
toenail dystrophy, isolated
|
[NCBI]
|
8.60362e-05
|
|
|
advanced sleep-phase syndrome, familial
|
[NCBI]
|
8.60362e-05
|
|
|
HBD
|
[NCBI]
|
8.10517e-05
|
|
|
2-@methylbutyryl-coa dehydrogenase deficiency
|
[NCBI]
|
7.83707e-05
|
|
|
ear wax, wet/dry
|
[NCBI]
|
7.83707e-05
|
|
|
GLRA3
|
[NCBI]
|
7.75607e-05
|
|
|
EGF
|
[NCBI]
|
7.64543e-05
|
|
|
stickler syndrome, type i, nonsyndromic ocular
|
[NCBI]
|
7.26907e-05
|
|
|
PBT
|
[NCBI]
|
7.26907e-05
|
|
|
spondyloepimetaphyseal dysplasia, strudwick type
|
[NCBI]
|
7.26907e-05
|
|
|
SCA8
|
[NCBI]
|
7.26907e-05
|
|
|
epidermolysis bullosa pruriginosa
|
[NCBI]
|
7.26907e-05
|
|
|
myoclonic epilepsy, neonatal, with suppression-burst pattern
|
[NCBI]
|
7.26907e-05
|
|
|
renal tubular acidosis, distal, with hemolytic anemia
|
[NCBI]
|
7.26907e-05
|
|
|
PRL
|
[NCBI]
|
7.16109e-05
|
|
|
AD
|
[NCBI]
|
7.13756e-05
|
|
|
macular dystrophy, vitelliform, adult-onset
|
[NCBI]
|
6.818e-05
|
|
|
lipomatosis, familial benign cervical
|
[NCBI]
|
6.818e-05
|
|
|
STL2
|
[NCBI]
|
6.818e-05
|
|
|
TTR
|
[NCBI]
|
6.78364e-05
|
|
|
VEGF
|
[NCBI]
|
6.74046e-05
|
|
|
GLRA2
|
[NCBI]
|
6.72812e-05
|
|
|
IRS1
|
[NCBI]
|
6.57349e-05
|
|
|
wolff-parkinson-white syndrome
|
[NCBI]
|
6.44421e-05
|
|
|
EAD
|
[NCBI]
|
6.44421e-05
|
|
|
cardiomyopathy, familial hypertrophic, with wolff-parkinson-white syndrome
|
[NCBI]
|
6.44421e-05
|
|
|
gamma-glutamylcysteine synthetase deficiency, hemolytic anemia due to
|
[NCBI]
|
6.44421e-05
|
|
|
cirrhosis, familial
|
[NCBI]
|
6.44421e-05
|
|
|
ED2
|
[NCBI]
|
6.44421e-05
|
|
|
MAP1LC3B
|
[NCBI]
|
6.3694e-05
|
|
|
pseudo-von willebrand disease
|
[NCBI]
|
6.12534e-05
|
|
|
OSMED
|
[NCBI]
|
6.12534e-05
|
|
|
WGN1
|
[NCBI]
|
6.12534e-05
|
|
|
3-@methylcrotonyl-coa carboxylase 2 deficiency
|
[NCBI]
|
6.12534e-05
|
|
|
complement factor i deficiency
|
[NCBI]
|
5.84753e-05
|
|
|
hypertriglyceridemia, familial
|
[NCBI]
|
5.84753e-05
|
|
|
IHCM
|
[NCBI]
|
5.84753e-05
|
|
|
myotonia, potassium-aggravated
|
[NCBI]
|
5.84753e-05
|
|
|
methylmalonic aciduria, cbla type
|
[NCBI]
|
5.60159e-05
|
|
|
ADRB1
|
[NCBI]
|
5.43873e-05
|
|
|
TSD
|
[NCBI]
|
5.38729e-05
|
|
|
NSHPT
|
[NCBI]
|
5.38112e-05
|
|
|
amyloidosis, primary cutaneous
|
[NCBI]
|
5.18146e-05
|
|
|
FHM2
|
[NCBI]
|
5.18146e-05
|
|
|
PCCA
|
[NCBI]
|
5.05183e-05
|
|
|
parkinson disease, mitochondrial
|
[NCBI]
|
4.99913e-05
|
|
|
cystathioninuria
|
[NCBI]
|
4.83145e-05
|
|
|
FMR1
|
[NCBI]
|
4.72796e-05
|
|
|
SLC6A5
|
[NCBI]
|
4.57163e-05
|
|
|
SLC25A32
|
[NCBI]
|
4.57163e-05
|
|
|
CFTR
|
[NCBI]
|
4.5313e-05
|
|
|
osteogenesis imperfecta, type iv
|
[NCBI]
|
4.39736e-05
|
|
|
canavan disease
|
[NCBI]
|
4.39736e-05
|
|
|
SUMF1
|
[NCBI]
|
4.3299e-05
|
|
|
GATM
|
[NCBI]
|
4.3299e-05
|
|
|
COL4A5
|
[NCBI]
|
4.31651e-05
|
|
|
MNGIE
|
[NCBI]
|
4.27102e-05
|
|
|
PSNP1
|
[NCBI]
|
4.15215e-05
|
|
|
UCMD
|
[NCBI]
|
4.15215e-05
|
|
|
osteogenesis imperfecta, type iii
|
[NCBI]
|
4.15215e-05
|
|
|
SEDC
|
[NCBI]
|
4.15215e-05
|
|
|
d-bifunctional protein deficiency
|
[NCBI]
|
4.15215e-05
|
|
|
PTH
|
[NCBI]
|
4.08914e-05
|
|
|
hyperlipoproteinemia, type i
|
[NCBI]
|
4.03994e-05
|
|
|
STL1
|
[NCBI]
|
4.03994e-05
|
|
|
hyperekplexia, hereditary
|
[NCBI]
|
4.03994e-05
|
|
|
CRC
|
[NCBI]
|
3.98708e-05
|
|
|
carbamoyl phosphate synthetase i deficiency, hyperammonemia due to
|
[NCBI]
|
3.93375e-05
|
|
|
FGG
|
[NCBI]
|
3.74777e-05
|
|
|
sotos syndrome
|
[NCBI]
|
3.73715e-05
|
|
|
SCA6
|
[NCBI]
|
3.64584e-05
|
|
|
FPGS
|
[NCBI]
|
3.61598e-05
|
|
|
HNFJ
|
[NCBI]
|
3.47526e-05
|
|
|
holocarboxylase synthetase deficiency
|
[NCBI]
|
3.47526e-05
|
|
|
HCH
|
[NCBI]
|
3.47526e-05
|
|
|
FPLD2
|
[NCBI]
|
3.39539e-05
|
|
|
mucopolysaccharidosis type vi
|
[NCBI]
|
3.39539e-05
|
|
|
PAM
|
[NCBI]
|
3.33699e-05
|
|
|
ATS
|
[NCBI]
|
3.31876e-05
|
|
|
ACAT1
|
[NCBI]
|
3.23347e-05
|
|
|
CEACAM5
|
[NCBI]
|
3.21796e-05
|
|
|
KRTAP13-1
|
[NCBI]
|
3.18432e-05
|
|
|
MAP1LC3C
|
[NCBI]
|
3.18432e-05
|
|
|
methylmalonic aciduria due to methylmalonyl-coa mutase deficiency
|
[NCBI]
|
3.10616e-05
|
|
|
FGFR3
|
[NCBI]
|
3.04476e-05
|
|
|
FCHL
|
[NCBI]
|
3.04043e-05
|
|
|
GLRA1
|
[NCBI]
|
3.02943e-05
|
|
|
PRKCG
|
[NCBI]
|
3.02943e-05
|
|
|
hyperoxaluria, primary, type i
|
[NCBI]
|
2.977e-05
|
|
|
VMD
|
[NCBI]
|
2.91572e-05
|
|
|
SLC6A8
|
[NCBI]
|
2.8594e-05
|
|
|
DRD3
|
[NCBI]
|
2.80851e-05
|
|
|
myoclonic epilepsy of unverricht and lundborg
|
[NCBI]
|
2.79916e-05
|
|
|
MADD
|
[NCBI]
|
2.79916e-05
|
|
|
GJB6
|
[NCBI]
|
2.76005e-05
|
|
|
CF
|
[NCBI]
|
2.69696e-05
|
|
|
HHC1
|
[NCBI]
|
2.68984e-05
|
|
|
HBG1
|
[NCBI]
|
2.68466e-05
|
|
|
mitochondrial complex i deficiency
|
[NCBI]
|
2.63765e-05
|
|
|
BCPM
|
[NCBI]
|
2.63765e-05
|
|
|
FGFR4
|
[NCBI]
|
2.54759e-05
|
|
|
DLD
|
[NCBI]
|
2.51002e-05
|
|
|
ITGA2B
|
[NCBI]
|
2.51002e-05
|
|
|
LPL
|
[NCBI]
|
2.50125e-05
|
|
|
leber optic atrophy
|
[NCBI]
|
2.49312e-05
|
|
|
COL17A1
|
[NCBI]
|
2.47382e-05
|
|
|
SLC17A7
|
[NCBI]
|
2.47382e-05
|
|
|
sulfatase-modifying factor 2
|
[NCBI]
|
2.44337e-05
|
|
|
GLY B+
|
[NCBI]
|
2.44337e-05
|
|
|
NOLA1
|
[NCBI]
|
2.44337e-05
|
|
|
SLC38A4
|
[NCBI]
|
2.44337e-05
|
|
|
GRIN3B
|
[NCBI]
|
2.44337e-05
|
|
|
PRMT8
|
[NCBI]
|
2.44337e-05
|
|
|
WBP4
|
[NCBI]
|
2.44337e-05
|
|
|
NGFB
|
[NCBI]
|
2.44241e-05
|
|
|
NPY
|
[NCBI]
|
2.37419e-05
|
|
|
hypophosphatemic rickets, x-linked dominant
|
[NCBI]
|
2.35436e-05
|
|
|
VIP
|
[NCBI]
|
2.17982e-05
|
|
|
ADRB2
|
[NCBI]
|
2.17043e-05
|
|
|
PSAT1
|
[NCBI]
|
2.16458e-05
|
|
|
SLC36A2
|
[NCBI]
|
2.16458e-05
|
|
|
PFAS
|
[NCBI]
|
2.16458e-05
|
|
|
ATG12
|
[NCBI]
|
2.16458e-05
|
|
|
TRG2
|
[NCBI]
|
2.16458e-05
|
|
|
CDO
|
[NCBI]
|
2.11965e-05
|
|
|
GNMT
|
[NCBI]
|
2.07143e-05
|
|
|
GRIN2D
|
[NCBI]
|
1.98402e-05
|
|
|
EIF2AK4
|
[NCBI]
|
1.98402e-05
|
|
|
BAAT
|
[NCBI]
|
1.98402e-05
|
|
|
GRIN3A
|
[NCBI]
|
1.98402e-05
|
|
|
CYP4F12
|
[NCBI]
|
1.98402e-05
|
|
|
POU3F3
|
[NCBI]
|
1.98402e-05
|
|
|
SLC36A1
|
[NCBI]
|
1.98402e-05
|
|
|
NDUFA1
|
[NCBI]
|
1.98402e-05
|
|
|
DPH2
|
[NCBI]
|
1.98402e-05
|
|
|
SHMT2
|
[NCBI]
|
1.98402e-05
|
|
|
HGPS
|
[NCBI]
|
1.87162e-05
|
|
|
SOD1
|
[NCBI]
|
1.85073e-05
|
|
|
GLRB
|
[NCBI]
|
1.85011e-05
|
|
|
IL10RA
|
[NCBI]
|
1.85011e-05
|
|
|
GRM2
|
[NCBI]
|
1.85011e-05
|
|
|
PPAT
|
[NCBI]
|
1.85011e-05
|
|
|
ETFA
|
[NCBI]
|
1.85011e-05
|
|
|
CYP4F8
|
[NCBI]
|
1.85011e-05
|
|
|
EIF4B
|
[NCBI]
|
1.85011e-05
|
|
|
ALS1
|
[NCBI]
|
1.80929e-05
|
|
|
LHCGR
|
[NCBI]
|
1.80668e-05
|
|
|
CFB
|
[NCBI]
|
1.75498e-05
|
|
|
DAO
|
[NCBI]
|
1.75498e-05
|
|
|
WT1
|
[NCBI]
|
1.74954e-05
|
|
|
SRI
|
[NCBI]
|
1.74369e-05
|
|
|
HOMER2
|
[NCBI]
|
1.74369e-05
|
|
|
SLC12A5
|
[NCBI]
|
1.74369e-05
|
|
|
FBP1
|
[NCBI]
|
1.74369e-05
|
|
|
MAP1LC3A
|
[NCBI]
|
1.74369e-05
|
|
|
PD
|
[NCBI]
|
1.73104e-05
|
|
|
CASR
|
[NCBI]
|
1.66293e-05
|
|
|
QKI
|
[NCBI]
|
1.65542e-05
|
|
|
MCCC1
|
[NCBI]
|
1.65542e-05
|
|
|
apnea, obstructive sleep
|
[NCBI]
|
1.62761e-05
|
|
|
ALDH4A1
|
[NCBI]
|
1.58006e-05
|
|
|
DVL2
|
[NCBI]
|
1.58006e-05
|
|
|
PSPH
|
[NCBI]
|
1.58006e-05
|
|
|
TARDBP
|
[NCBI]
|
1.58006e-05
|
|
|
HSD17B3
|
[NCBI]
|
1.58006e-05
|
|
|
tritanopia
|
[NCBI]
|
1.58006e-05
|
|
|
MCCC2
|
[NCBI]
|
1.58006e-05
|
|
|
GNAT2
|
[NCBI]
|
1.58006e-05
|
|
|
FUT6
|
[NCBI]
|
1.58006e-05
|
|
|
ASL
|
[NCBI]
|
1.57348e-05
|
|
|
ARSA
|
[NCBI]
|
1.54652e-05
|
|
|
GART
|
[NCBI]
|
1.51435e-05
|
|
|
COLQ
|
[NCBI]
|
1.51435e-05
|
|
|
PTGER2
|
[NCBI]
|
1.51435e-05
|
|
|
VRK1
|
[NCBI]
|
1.51435e-05
|
|
|
GNAI1
|
[NCBI]
|
1.51435e-05
|
|
|
GSTZ1
|
[NCBI]
|
1.51435e-05
|
|
|
MB
|
[NCBI]
|
1.474e-05
|
|
|
GUCA1A
|
[NCBI]
|
1.45613e-05
|
|
|
APOA5
|
[NCBI]
|
1.45613e-05
|
|
|
GNAO1
|
[NCBI]
|
1.45613e-05
|
|
|
HOMER1
|
[NCBI]
|
1.45613e-05
|
|
|
TRPC1
|
[NCBI]
|
1.45613e-05
|
|
|
GCGR
|
[NCBI]
|
1.45613e-05
|
|
|
EGFR
|
[NCBI]
|
1.42306e-05
|
|
|
AR
|
[NCBI]
|
1.42012e-05
|
|
|
DPEP1
|
[NCBI]
|
1.40389e-05
|
|
|
ADSS
|
[NCBI]
|
1.40389e-05
|
|
|
PEX1
|
[NCBI]
|
1.40389e-05
|
|
|
C1QA
|
[NCBI]
|
1.40389e-05
|
|
|
SLC30A3
|
[NCBI]
|
1.40389e-05
|
|
|
HEXA
|
[NCBI]
|
1.35666e-05
|
|
|
IL12RB1
|
[NCBI]
|
1.35655e-05
|
|
|
COL4A4
|
[NCBI]
|
1.35655e-05
|
|
|
thrombasthenia of glanzmann and naegeli
|
[NCBI]
|
1.32591e-05
|
|
|
COL6A3
|
[NCBI]
|
1.31327e-05
|
|
|
ATG5
|
[NCBI]
|
1.31327e-05
|
|
|
FMO1
|
[NCBI]
|
1.31327e-05
|
|
|
HGF
|
[NCBI]
|
1.28636e-05
|
|
|
PPARA
|
[NCBI]
|
1.28207e-05
|
|
|
ECGF1
|
[NCBI]
|
1.27344e-05
|
|
|
ETF1
|
[NCBI]
|
1.27344e-05
|
|
|
CJD
|
[NCBI]
|
1.26847e-05
|
|
|
TNNI3
|
[NCBI]
|
1.23656e-05
|
|
|
GRM1
|
[NCBI]
|
1.23656e-05
|
|
|
LOR
|
[NCBI]
|
1.23656e-05
|
|
|
RHAG
|
[NCBI]
|
1.23656e-05
|
|
|
CCK
|
[NCBI]
|
1.21445e-05
|
|
|
GPHN
|
[NCBI]
|
1.20224e-05
|
|
|
GRIN2A
|
[NCBI]
|
1.20224e-05
|
|
|
PRKCA
|
[NCBI]
|
1.20224e-05
|
|
|
AGL
|
[NCBI]
|
1.20224e-05
|
|
|
CRYBA1
|
[NCBI]
|
1.20224e-05
|
|
|
COL11A1
|
[NCBI]
|
1.20224e-05
|
|
|
SEMA4D
|
[NCBI]
|
1.20224e-05
|
|
|
ABCB11
|
[NCBI]
|
1.17601e-05
|
|
|
AGXT
|
[NCBI]
|
1.17015e-05
|
|
|
RALGDS
|
[NCBI]
|
1.17015e-05
|
|
|
SELE
|
[NCBI]
|
1.17015e-05
|
|
|
UGDH
|
[NCBI]
|
1.14003e-05
|
|
|
GJD2
|
[NCBI]
|
1.14003e-05
|
|
|
COL11A2
|
[NCBI]
|
1.11167e-05
|
|
|
KCNE1
|
[NCBI]
|
1.11167e-05
|
|
|
FGB
|
[NCBI]
|
1.11167e-05
|
|
|
TNF
|
[NCBI]
|
1.11114e-05
|
|
|
FBN1
|
[NCBI]
|
1.11068e-05
|
|
|
NCSTN
|
[NCBI]
|
1.08487e-05
|
|
|
SCNN1B
|
[NCBI]
|
1.08487e-05
|
|
|
PER2
|
[NCBI]
|
1.08487e-05
|
|
|
HSD17B4
|
[NCBI]
|
1.05949e-05
|
|
|
MPO
|
[NCBI]
|
1.05185e-05
|
|
|
BHMT
|
[NCBI]
|
1.03538e-05
|
|
|
CDSN
|
[NCBI]
|
1.03538e-05
|
|
|
NME1
|
[NCBI]
|
1.03538e-05
|
|
|
RET
|
[NCBI]
|
1.02205e-05
|
|
|
PPIA
|
[NCBI]
|
1.01511e-05
|
|
|
SLC1A1
|
[NCBI]
|
1.01243e-05
|
|
|
XPC
|
[NCBI]
|
9.90541e-06
|
|
|
HTR2A
|
[NCBI]
|
9.90541e-06
|
|
|
TH
|
[NCBI]
|
9.8919e-06
|
|
|
CA1
|
[NCBI]
|
9.69624e-06
|
|
|
ALD
|
[NCBI]
|
9.60617e-06
|
|
|
CACNA1C
|
[NCBI]
|
9.304e-06
|
|
|
SLC17A6
|
[NCBI]
|
9.304e-06
|
|
|
MTCO3
|
[NCBI]
|
9.304e-06
|
|
|
SPTB
|
[NCBI]
|
9.11963e-06
|
|
|
UCP1
|
[NCBI]
|
9.06323e-06
|
|
|
SLN
|
[NCBI]
|
8.94236e-06
|
|
|
phenylketonuria ii
|
[NCBI]
|
8.94236e-06
|
|
|
C1NH
|
[NCBI]
|
8.60716e-06
|
|
|
SLC25A4
|
[NCBI]
|
8.60716e-06
|
|
|
PLD2
|
[NCBI]
|
8.60716e-06
|
|
|
GCH1
|
[NCBI]
|
8.44841e-06
|
|
|
GP1BA
|
[NCBI]
|
8.44841e-06
|
|
|
ARSB
|
[NCBI]
|
8.44841e-06
|
|
|
PRODH
|
[NCBI]
|
8.44841e-06
|
|
|
IRS2
|
[NCBI]
|
8.29505e-06
|
|
|
DCN
|
[NCBI]
|
8.29505e-06
|
|
|
GRIN1
|
[NCBI]
|
8.29505e-06
|
|
|
DDOST
|
[NCBI]
|
8.14677e-06
|
|
|
COL6A1
|
[NCBI]
|
8.14677e-06
|
|
|
MTTK
|
[NCBI]
|
8.00326e-06
|
|
|
ADH5
|
[NCBI]
|
7.86425e-06
|
|
|
PRPH2
|
[NCBI]
|
7.86425e-06
|
|
|
PSEN1
|
[NCBI]
|
7.81843e-06
|
|
|
STAT5B
|
[NCBI]
|
7.7295e-06
|
|
|
GRPR
|
[NCBI]
|
7.59877e-06
|
|
|
NPPA
|
[NCBI]
|
7.54314e-06
|
|
|
MTCO1
|
[NCBI]
|
7.47184e-06
|
|
|
AVP
|
[NCBI]
|
7.34344e-06
|
|
|
KSS
|
[NCBI]
|
7.22652e-06
|
|
|
TPI1
|
[NCBI]
|
7.11205e-06
|
|
|
SCN4A
|
[NCBI]
|
6.99856e-06
|
|
|
complement component 2 deficiency
|
[NCBI]
|
6.99856e-06
|
|
|
TACR1
|
[NCBI]
|
6.99856e-06
|
|
|
TLR4
|
[NCBI]
|
6.83143e-06
|
|
|
PDYN
|
[NCBI]
|
6.78033e-06
|
|
|
MTCYB
|
[NCBI]
|
6.78033e-06
|
|
|
GRIA1
|
[NCBI]
|
6.67533e-06
|
|
|
SLC6A6
|
[NCBI]
|
6.67533e-06
|
|
|
DSG1
|
[NCBI]
|
6.67533e-06
|
|
|
LPA
|
[NCBI]
|
6.57292e-06
|
|
|
ornithine aminotransferase deficiency
|
[NCBI]
|
6.47299e-06
|
|
|
GFAP
|
[NCBI]
|
6.40394e-06
|
|
|
AMACR
|
[NCBI]
|
6.37544e-06
|
|
|
factor x deficiency
|
[NCBI]
|
6.28016e-06
|
|
|
CACNA1A
|
[NCBI]
|
6.09608e-06
|
|
|
SCN5A
|
[NCBI]
|
6.09608e-06
|
|
|
MYH7
|
[NCBI]
|
6.09608e-06
|
|
|
phenylketonuria
|
[NCBI]
|
5.95627e-06
|
|
|
DHFR
|
[NCBI]
|
5.91984e-06
|
|
|
GALT
|
[NCBI]
|
5.83492e-06
|
|
|
PJS
|
[NCBI]
|
5.73296e-06
|
|
|
RLBP1
|
[NCBI]
|
5.59001e-06
|
|
|
KIT
|
[NCBI]
|
5.59001e-06
|
|
|
FAAH
|
[NCBI]
|
5.43746e-06
|
|
|
F13A1
|
[NCBI]
|
5.43494e-06
|
|
|
UMOD
|
[NCBI]
|
5.43494e-06
|
|
|
RPGR
|
[NCBI]
|
5.43494e-06
|
|
|
NFKB1
|
[NCBI]
|
5.28593e-06
|
|
|
F2
|
[NCBI]
|
5.21357e-06
|
|
|
porphyria cutanea tarda
|
[NCBI]
|
5.21357e-06
|
|
|
NP
|
[NCBI]
|
5.00455e-06
|
|
|
BTC
|
[NCBI]
|
4.93743e-06
|
|
|
tyrosinemia, type i
|
[NCBI]
|
4.93743e-06
|
|
|
TYMS
|
[NCBI]
|
4.89439e-06
|
|
|
NR5A1
|
[NCBI]
|
4.80678e-06
|
|
|
PARK2
|
[NCBI]
|
4.49958e-06
|
|
|
DRD4
|
[NCBI]
|
4.49958e-06
|
|
|
APOD
|
[NCBI]
|
4.38384e-06
|
|
|
PENK
|
[NCBI]
|
4.38384e-06
|
|
|
FSHR
|
[NCBI]
|
4.38384e-06
|
|
|
SLC4A1
|
[NCBI]
|
4.3274e-06
|
|
|
ANG
|
[NCBI]
|
4.27187e-06
|
|
|
RYR1
|
[NCBI]
|
4.21723e-06
|
|
|
factor v deficiency
|
[NCBI]
|
4.05844e-06
|
|
|
GBA
|
[NCBI]
|
3.90691e-06
|
|
|
SRY
|
[NCBI]
|
3.85792e-06
|
|
|
SLC11A2
|
[NCBI]
|
3.76213e-06
|
|
|
APOB
|
[NCBI]
|
3.72528e-06
|
|
|
SMN1
|
[NCBI]
|
3.7153e-06
|
|
|
PLN
|
[NCBI]
|
3.62366e-06
|
|
|
HRG
|
[NCBI]
|
3.44812e-06
|
|
|
AQP1
|
[NCBI]
|
3.40577e-06
|
|
|
AKR1B1
|
[NCBI]
|
3.19419e-06
|
|
|
LMNA
|
[NCBI]
|
3.12509e-06
|
|
|
ASS
|
[NCBI]
|
2.80055e-06
|
|
|
ATM
|
[NCBI]
|
2.76676e-06
|
|
|
homocystinuria
|
[NCBI]
|
2.73339e-06
|
|
|
MAPK1
|
[NCBI]
|
2.70043e-06
|
|
|
GAPDH
|
[NCBI]
|
2.50738e-06
|
|
|
CCND1
|
[NCBI]
|
2.48079e-06
|
|
|
POMC
|
[NCBI]
|
2.47362e-06
|
|
|
MAPT
|
[NCBI]
|
2.45092e-06
|
|
|
SOD2
|
[NCBI]
|
2.41917e-06
|
|
|
BCHE
|
[NCBI]
|
2.36317e-06
|
|
|
HPRT1
|
[NCBI]
|
2.33492e-06
|
|
|
von willebrand disease
|
[NCBI]
|
2.06769e-06
|
|
|
CHAT
|
[NCBI]
|
2.05497e-06
|
|
|
INSR
|
[NCBI]
|
2.01783e-06
|
|
|
ADA
|
[NCBI]
|
1.96496e-06
|
|
|
COMT
|
[NCBI]
|
1.91494e-06
|
|
|
HBA2
|
[NCBI]
|
1.80686e-06
|
|
|
ABCB1
|
[NCBI]
|
1.7847e-06
|
|
|
STAT5A
|
[NCBI]
|
1.67746e-06
|
|
|
LEP
|
[NCBI]
|
1.51756e-06
|
|
|
PLK1
|
[NCBI]
|
1.47969e-06
|
|
|
hemophilia a
|
[NCBI]
|
1.35334e-06
|
|
|
AGER
|
[NCBI]
|
1.26866e-06
|
|
|
RP
|
[NCBI]
|
1.23299e-06
|
|
|
TFPI
|
[NCBI]
|
1.12968e-06
|
|
|
IL6
|
[NCBI]
|
1.11212e-06
|
|
|
LCAT
|
[NCBI]
|
1.10688e-06
|
|
|
PYY
|
[NCBI]
|
1.05569e-06
|
|
|
RTT
|
[NCBI]
|
1.05526e-06
|
|
|
APP
|
[NCBI]
|
1.02578e-06
|
|
|
MUC1
|
[NCBI]
|
1.01331e-06
|
|
|
PMP22
|
[NCBI]
|
9.71167e-07
|
|
|
SLC18A3
|
[NCBI]
|
8.93422e-07
|
|
|
EPOR
|
[NCBI]
|
8.80934e-07
|
|
|
ACE
|
[NCBI]
|
8.3078e-07
|
|
|
FGF7
|
[NCBI]
|
7.11704e-07
|
|
|
PRNP
|
[NCBI]
|
6.87637e-07
|
|
|
ACHE
|
[NCBI]
|
6.5357e-07
|
|
|
GRP
|
[NCBI]
|
6.37139e-07
|
|
|
PEDF
|
[NCBI]
|
6.08123e-07
|
|
|
amyloidosis vi
|
[NCBI]
|
6.00772e-07
|
|
|
PF4
|
[NCBI]
|
5.50159e-07
|
|
|
BDNF
|
[NCBI]
|
4.67737e-07
|
|
|
SPP1
|
[NCBI]
|
4.60284e-07
|
|
|
TP53
|
[NCBI]
|
3.65525e-07
|
|
|
TF
|
[NCBI]
|
3.14331e-07
|
|
|
F3
|
[NCBI]
|
2.98655e-07
|
|
|
SHH
|
[NCBI]
|
2.79857e-07
|
|
|
PDCD8
|
[NCBI]
|
2.40235e-07
|
|
|
polycystic kidneys
|
[NCBI]
|
1.87917e-07
|
|
|
G6PD
|
[NCBI]
|
1.83745e-07
|
|
|
MAG
|
[NCBI]
|
1.65616e-07
|
|
|
AMH
|
[NCBI]
|
1.30564e-07
|
|
|
SLC6A3
|
[NCBI]
|
1.15958e-07
|
|
|
ABCC1
|
[NCBI]
|
1.13158e-07
|
|
|
SRF
|
[NCBI]
|
1.13158e-07
|
|
|
FTD
|
[NCBI]
|
5.29276e-08
|
|
|
IAPP
|
[NCBI]
|
4.66355e-08
|
|
|
TNFSF6
|
[NCBI]
|
4.12915e-08
|
|
|
PNMT
|
[NCBI]
|
2.56865e-08
|
|
|
ACPP
|
[NCBI]
|
2.1088e-08
|
|
|
MBL2
|
[NCBI]
|
1.64831e-08
|
|
|
RASA1
|
[NCBI]
|
1.12087e-08
|
|
|
CAT
|
[NCBI]
|
8.12047e-09
|
|
|
SLC6A4
|
[NCBI]
|
2.42886e-11
|
|